Valion Bio, Inc. Other Nonoperating Income
Valion Bio, Inc. (VBIO) reported Other Nonoperating Income of $1.00 thousand for the 1-month period ending 2022-01-31, per its 10-Q filed 2022-05-16.
Discontinued › Income Statement › Other Income
us-gaap:OtherNonoperatingIncome · last filed 2023-03-31
- Valion Bio, Inc. other nonoperating income for the quarter ending 2021-06-30 was $156.00K.
- Valion Bio, Inc. other nonoperating income for the quarter ending 2021-03-31 was $2.00K.
- Valion Bio, Inc. other nonoperating income for fiscal 2021 was $162.00K.
| Period end | Other Nonoperating Income 1 month | Other Nonoperating Income 3 month | Other Nonoperating Income 6 month | Other Nonoperating Income 12 month |
|---|---|---|---|---|
| 2022-01-31 | $1.00K 10-Q · filed 2022-05-16 | |||
| 2021-12-31 | $162.00K 10-K · filed 2023-03-31 | |||
| 2021-06-30 | $156.00K 10-Q · filed 2022-08-15 | $158.00K 10-Q · filed 2022-08-15 | ||
| 2021-03-31 | $2.00K 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |